Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ketanserin
Cat. No.:
OB0225LY-0414
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Ketanserin is a 5-HT2 receptor antagonist that has been used primarily to study its role in vasodilation and blood pressure regulation.
Synonym:
R41468; Ketanserin tartrate; Ketanserinum; 74050-98-9; 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione; 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione
CAS No.:
74050-98-9
Compound CID:
3822
Formula:
C22H22FN3O3
Formula Weight:
395.43
Specification
Relative Density:
1.280 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ketanserin can be used to explore its importance in models of cardiovascular disease.
Library Information
Targets:
5-HT receptor; Potassium channel
Receptors:
5-HT2A receptor; 5-HT2C receptor
Pathways:
Autophagy; Membrane transporter/Ion channel; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-6
Plate Location:
c10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
9 mg/mL; 22.76 mM
